|
|
REFINE ICD - OVERVIEW
An overview of the REFINE ICD trial is shown:
Hypotheses
Primary:
An ICD compared to usual care will increase survival in patients
with an EF 0.36 to 0.50, impaired heart rate turbulence
(HRT) and abnormal repolarization alternans (TWA) measured
at least 2 months
after MI. |
Secondary:
•
Compare cardiac death rates in ICD vs. control patients.
•
Assess rates of appropriate ICD therapies in ICD patients.
•
Compare arrhythmic syncope rates in ICD vs. control patients.
•
Compare temporal patterns of health-related quality of life in ICD
vs. control patients.
•
Evaluate the prognostic significance of DC, in addition to HRT and
TWA.
|
|
|
|
Home |
News |
Study |
Resources |
Support |
Links |
Sitemap |
Disclaimer |
|
REFINE ICD Clinical Coordinating Centre: TRW Building GE63, 3280
Hospital Drive NW, Calgary, AB, T2N 4Z6, Canada | Phone: 1-855-426-6328 | Fax: (403) 210-8140 |
Contact Us
|
